Effect of systemic N-methyl-D-aspartate receptor antagonist (ketamine) on primary and secondary hyperalgesia in humans

British Journal of Anaesthesia

Volumn 76, Issue 6, 1996, Pages 829-834

  Ilkjaer, S ^a   Petersen, K L ^b   Brennum, J ^b   Wernberg, M ^a   Dahl, J B ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Anaesthetics i.v., ketamine; Burns; Pain, mechanism; Pain, postoperative

Indexed keywords

KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ADULT; ANALGESIA; ARTICLE; BURN; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DROWSINESS; HALLUCINATION; HUMAN; HUMAN EXPERIMENT; HYPERALGESIA; HYPERSENSITIVITY; INFUSION PUMP; INTRAVENOUS DRUG ADMINISTRATION; MALE; MODEL; NOCICEPTION; NORMAL HUMAN; PRIORITY JOURNAL; THERMAL STIMULATION;

EID: 0030006460     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/76.6.829     Document Type: Article

References (32)

1. Woolf CJ. Central mechanisms of acute pain. In: Bond MR, Charlton JE, Woolf CJ, eds. Proceedings of the VIth World Congress on Pain. Amsterdam: Elsevier, 1991; 25-34.
2. Woolf CJ. Somatic pain - pathogenesis and prevention. British Journal of Anaesthesia 1995; 75: 169-176.
3. Dickenson AH. NMDA receptor antagonists as analgesics. In: Fields HL, Liebeskind JC, eds. Pharmacological Approaches to the Treatment of Chronic Pain: New Concepts and Critical Issues (Progress in Pain Research and Management, vol. 1). Seattle: IASP Press, 1994; 173-187.
4. Reich DL, Silvay G. Ketamine: an update of the first twentyfive years of clinical experience. Canadian Journal of Anaesthesia 1989; 36: 186-197.
5. Lodge D, Johsson KM. Noncompetitive excitatory amino acid antagonists. Trends in Pharmacological Science 1990; 11: 81-86.
6. Haley JE, Sullivan AF, Dickenson AH. Evidence for spinal N-methyl-D-aspartate receptor involvement in prolonged chemical nociception in the rat. Brain Research 1990; 518: 218-226.
7. Naguib M, Sharif AMY, Seraj M, El Gammal M, Dawlatly AA. Ketamine for caudal analgesia in children: comparison with caudal bupivacaine. British Journal of Anaesthesia 1991; 67: 559-564.
8. Edwards ND, Fletcher A, Cole JR, Peacock JE. Combined infusions of morphine and ketamine for postoperative pain in elderly patients. Anaesthesia 1993; 48: 124-127.
9. Roytblat L, Korotkoruchko A, Katz J, Glazer M, Greemberg L, Fisher A. Postoperative pain: The effect of low-dose ketamine in addition to general anesthesia. Anesthesia and Analgesia 1993; 77: 1161-1165.
10. Tverskoy M, Oz Y, Isakson A, Finger J, Bradley EL, Kissin I. Preemptive Effect of fentanyl and ketamine on postoperative pain and wound hyperalgesia. Anesthesia and Analgesia 1994; 78: 205-209.
11. Eide PK, Jørum E, Stubhaug A, Bremnes J, Breivik H. Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo. Pain 1994; 58: 347-354.
12. Backonja M, Arndt G, Gombar KA, Check B, Zimmermann M. Response of chronic neuropathic pain syndromes to ketamine: a preliminary study. Pain 1994; 56: 51-57.
13. Treede RD, Meyer RA, Raja SN, Campbell JN. Peripheral and central mechanisms of cutaneous hyperalgesia. Progress in Neurobiology 1992; 38: 397-421.
14. Baumann TK, Simone DA, Shain CN, LaMotte RH. Neurogenic hyperalgesia: the search for the primary cutaneous afferent fibers that contribute to capsaicin-induced pain and hyperalgesia. Journal of Neurophysiology 1991; 66: 212-227.
15. LaMotte RH, Lundberg LER, Torebjörk HE. Pain, hyperalgesia and activity in nociceptive C units in humans after intradermal injection of capsaicin. Journal of Physiology (London) 1992; 448: 749-764.
16. LaMotte RH, Shain CN, Simone DA, Tsai EFP. Neurogenic hyperalgesia: psychophysical studies of underlying mechanisms. Journal of Neurophysiology 1991; 66: 190-211.
17. Simone DA, Sorkin LS, Oh O, Chung JM, Owens C, LaMotte RH, Willis WD. Neurogenic hyperalgesia: central neural correlates in responses of spinothalamic tract neurons. Journal of Neurophysiology 1991; 66: 228-246.
18. Torebjörk E, Lundberg L, LaMotte R. Central changes in processing of mechanoreceptive input in capsaicin-induced secondary hyperalgesia in humans. Journal of Physiology (London) 1992; 448: 765-780.
19. Dahl JB, Brennum J, Arendt-Nielsen L, Jensen TS, Kehlet H. The effect of pre-versus postinjury infiltration with lidocaine on thermal and mechanical hyperalgesia after heat injury to the skin. Pain 1993; 53: 43-51.
20. Brennum J, Dahl JB, Møiniche S, Arendt-Nielsen L. Quantitative sensory examination during epidural anaesthesia and analgesia in man. Effects of preemptive and posttraumatic morphine on hyperalgesia. Pain 1994; 59: 261-271.
21. Dickenson AH, Sullivan AF. Evidence for a role of the NMDA receptor in the frequency dependent potentiation of the deep dorsal horn neurones following C-fibre stimulation. Neuropharmacology 1987; 26: 1235-1238.
22. Dickenson AH, Sullivan AF. Electrophysiological studies on the effects of intrathecal morphine on nociceptive neurones in the rat dorsal horn. Pain 1986; 24: 211-222.
23. Davies SN, Lodge D. Evidence for involvement of N-methyl-D-aspartate receptors in "wind-up" of class 2 neurones in the dorsal horn of the rat. Brain Research 1987; 424: 402-406.
24. Price DD, Mao J, Frenk H, Mayer DJ. The N-methyl-D-aspartate receptor antagonist dextromethorphan selectively reduces temporal summation of second pain in man. Pain 1994; 59: 165-174.
25. Arendt-Nielsen L, Petersen-Felix S, Fischer M, Bak P, Bjerring P, Zbinden AM. The effect of N-methyl-D-aspartate antagonist (ketamine) on single and repeated nociceptive stimuli: a placebo-controlled experimental human study. Anesthesia and Analgesia 1995; 81: 63-68.
26. Park KM, Max MB, Robinovitz E, Gracely RH, Bennett GJ. Effects of intravenous ketamine and alfentanil on hyperalgesia induced by intradermal capsaicin. In: Gebhart DL, Hammond DL, Jensen TS, eds. Proceedings of the 7th World Congress on Pain. Seattle: IASP Press, 1994; 173-187.
27. Segerdahl M, Ekblom A, Sollevi A. The influence of adenosine, ketamine, and morphine on experimentally induced ischemic pain in healthy volunteers. Anesthesia and Analgesia 1994; 79: 787-791.
28. Lee K-C, Wilder RT, Smith RL, Berde CB. Thermal hyperalgesia accelerates and MK-801 prevents the development of tachyphylaxis to rat sciatic nerve blockade. Anesthesiology 1994; 81: 1284-1293.
29. Elliot K, Hynansky A, Inturrisi CE. Dextromethorphan attenuates and reverses analgesic tolerance to morphine. Pain 1994; 59: 361-368.
30. Chapman V, Dickenson AH. The combination of NMDA antagonism and morphine produces profound antinociception in the rat dorsal horn. Brain Research 1992; 573: 321-323.
31. Yamamoto T, Yaksh TL. Studies on the spinal interaction of morphine and the NMDA antagonist MK-801 on the hyperesthesia observed in a rat model of sciatic mononeuropathy. Neuroscience Letters 1992; 135: 67-70.
32. Mao J, Price DD, Mayer DJ, Lu J, Hayes RL. Intrathecal MK-801 and local nerve anaesthesia synergistically reduce nociceptive behaviours in rats with experimental peripheral mononeuropathy. Brain Research 1992; 576: 254-262.